Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
81. |
ECCT/25/01/03 | FETAL LITE STUDY Evaluation of Fetal Lite Device for Reducing Perinatal Mortality through Enhanced Labor Monitoring in Low-Resource Settings: A Pilot Study at Kenyatta National Hospital |
Principal Investigator(s) 1. GEORGE GWAKO 2. Alfred Osoti 3. Rosa Chemwey Site(s) in Kenya Kenyatta National Hospital |
13-05-2025 |
View |
82. |
ECCT/24/12/03 | PrEMIA Implementation study Multi-product PrEP delivery to young women seeking reproductive health services and coverage of HIV prevention |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya KEMRI-CCR PHRD( (THIKA) PROJECT |
04-05-2025 |
View |
83. |
ECCT/24/10/04 | Cabotegravir + Rilpivirine Inj A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Long-acting Combination Therapy Studies |
Principal Investigator(s) 1. Josphat Kosgei Site(s) in Kenya 1. Kenya Medical Research Institute/Walter Reed Project Clinical Research Centre (Kericho county) 2. School of Medicine, College of Health Sciences, Moi University (Uasin Gishu county) 3. Aga Khan University Hospital Nairobi (Nairobi City county) 4. University of Nairobi - Kenyatta National Referral Hospital (Nairobi City county) 5. University of Nairobi - Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) |
30-04-2025 |
View |
84. |
ECCT/25/04/07 | Server migration Server Migration |
Principal Investigator(s) 1. Server Migration Server Migration Site(s) in Kenya Server Migration |
30-04-2025 |
View |
85. |
ECCT/24/10/05 | Cabotegravir + Rilpivirine Inj A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Long-acting Combination Therapy Studies |
Principal Investigator(s) 1. Abraham Siika Site(s) in Kenya 1. Aga Khan University Hospital Nairobi (Nairobi City county) 2. School of Medicine, College of Health Sciences, Moi University (Uasin Gishu county) 3. Kenya Medical Research Institute-Walter Reed Program (KEMRI-WRP) Clinical Research Site, Kericho (Kericho county) 4. University of Nairobi - Kenyatta National Referral Hospital (Nairobi City county) 5. University of Nairobi - Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) |
29-04-2025 |
View |
86. |
ECCT/25/02/02 | HPV vaccine feasibility study Generating local data on HPV vaccination impact and training needs at the level of vaccine implementers – A feasibility study |
Principal Investigator(s) 1. Prof Kenneth Ngure Site(s) in Kenya KEMRI-CCR PHRD( (THIKA) PROJECT |
29-04-2025 |
View |
87. |
ECCT/25/01/01 | FLORAL An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study. |
Principal Investigator(s) 1. Bernhard Ogutu Site(s) in Kenya 1. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county) 2. Gertrude’s Children’s Hospital (Nairobi City county) 3. KEMRI Siaya Clinical Research Annex (Siaya county) 4. KEMRI/ WRAIR-Africa, Kombewa Clinical Research Center (Kisumu county) 5. KEMRI WALTER REED KERICHO (Kericho county) 6. KEMRI Kondele Children\'s Hospital (Kisumu county) 7. KEMRI/ WRAIR-Africa, Kombewa Clinical Research Center (Kisumu county) |
24-04-2025 |
View |
88. |
ECCT/24/07/02 | TMC278LAHTX4002 A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Longacting Combination Therapy Studies |
Principal Investigator(s) 1. Reena Shah Site(s) in Kenya 1. Aga Khan University Hospital Nairobi (Nairobi City county) 2. School of Medicine, College of Health Sciences, Moi University (Uasin Gishu county) 3. Kenya Medical Research Institute-Walter Reed Program (KEMRI-WRP) Clinical Research Site, Kericho, Kenya (Kericho county) 4. University of Nairobi - Kenyatta National Referral Hospital (Nairobi City county) 5. University of Nairobi - Jaramogi Oginga Odinga Teaching and Referral Hospital (Nairobi City county) |
16-04-2025 |
View |
89. |
ECCT/24/12/01 | PDMC-Saves Lives (PDMC-SL) Delivery strategies for malaria chemoprevention in the post-discharge management of hospitalised children with severe anaemia or severe malaria: cluster and individually randomised controlled implementation trials with nested economic evaluation in Kenya and Benin |
Principal Investigator(s) 1. Juliet Otieno Awori 2. Simon Kariuki Site(s) in Kenya Health facilities with blood transfusion services in malaria-endemic areas in Western Kenya |
16-04-2025 |
View |
90. |
ECCT/24/10/03 | EDE Scanner Study A non-interventional clinical validation study of the Exponential Deep Examination (EDE) scanner in the detection of human immunodeficiency virus (HIV), tuberculosis (TB) and malaria |
Principal Investigator(s) 1. VIDELIS Nduba 2. Berngards Ogutu Site(s) in Kenya 1. Ahero Clinical Trials Unit (Kisumu county) 2. KEMRI/CRDR Siaya Clinical trials Annex (Siaya county) 3. VICTORIA BIOMEDICAL RESEARCH INSTITUTE (Kisumu county) |
07-04-2025 |
View |